← Eichor
Condition: Eosinophilic Pulmonary Diseases Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Eosinophilic Pulmonary Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Charact
Phase N/A · 1 location(s) · Medical University Innsbruck · NCT04538937VCRC Tissue Repository
Phase N/A · 8 location(s) · University of Pennsylvania · NCT02967068Predictive Signature of Benralizumab Response
Phase 4 · 20 location(s) · Nantes University Hospital · NCT04565483A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Phase 2 · 58 location(s) · Kymera Therapeutics, Inc. · NCT07323654One-Time DNA Study for Vasculitis
Phase N/A · 14 location(s) · University of Pennsylvania · NCT01241305Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
Phase 3 · 50 location(s) · GlaxoSmithKline · NCT06979323A Non-interventional, Prospective Study With Benralizumab
Phase N/A · 41 location(s) · AstraZeneca · NCT06422078Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and T
Phase 3 · 15 location(s) · GlaxoSmithKline · NCT06959095Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
Phase N/A · 10 location(s) · Peter Merkel · NCT03004326Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontroll
Phase 3 · 160 location(s) · AstraZeneca · NCT06750289Institutional Registry of Rare Diseases
Phase N/A · 1 location(s) · Hospital Italiano de Buenos Aires · NCT06573723This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patient
Phase N/A · 36 location(s) · AstraZeneca · NCT06862206SIM0718 Treatment of Asthma Clinical Study
Phase 3 · 1 location(s) · Simcere Pharmaceutical Co., Ltd · NCT06488755A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy
Phase N/A · 28 location(s) · AstraZeneca · NCT07214753Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
Phase 2 · 1 location(s) · National Jewish Health · NCT02947945Vasculitis Pregnancy Registry
Phase N/A · 1 location(s) · University of Pennsylvania · NCT02593565The Study of Differences in Eosinophil Function and Subsets in Patients With Eosinophilic Pulmonary Diseases
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT06944418Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Con
Phase 3 · 213 location(s) · Sanofi · NCT07190222Therapeutic Relevance of Abnormal Airway Morphology in Asthma
Phase 4 · 2 location(s) · McMaster University · NCT06970080Allergy and Immunology Natural History Study
Phase N/A · 1 location(s) · Columbia University · NCT05584488eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (CO
Phase 3 · 121 location(s) · GlaxoSmithKline · NCT07177339Efficacy and Safety Study of 610 in Patients With Severe Asthma
Phase 3 · 1 location(s) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · NCT06323213Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and T
Phase 3 · 159 location(s) · GlaxoSmithKline · NCT06961214Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Con
Phase 3 · 215 location(s) · Sanofi · NCT07190209
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.